A STUDENT Sample Clauses

A STUDENT. OF (title of the training course or higher education curriculum being followed by the intern): (ETUDIANT EN (intitulé de la formation ou du cursus de l’enseignement supérieur suivi par le ou la stagiaire )) ……………………………………………………………………………………………………………………………………………………………………………………… AT (name of the higher education institution or training organization) (AU SEIN de (nom de l’établissement d’enseignement supérieur ou de l’organisme de formation)): ……………………………………………………………………………………………………………………………………………………………………………………… has completed an internship as part of his/her studies (a effectué un stage prévu dans le cadre de ses études) INTERNSHIP DURATION (DUREE DU STAGE) ………………………………………………………………………………… Internship start and end dates: From (Du) ……DD/MM/YYYY……………… To (Au) …………DD/MM/YYYY………………… (Dates de début et de fin du stage) Representing a total duration of (Number of months / Number of Weeks) (cross out any inappropriate item) (Représentant une durée totale de) ((Nbre de Mois / Nbre de Semaines) (rayer la mention inutile)) The total duration of the internship is assessed in consideration of the actual presence of the student within the organization, subject any authorized time off and leaves of absence granted, as provided under article L.124-13 of the education code (art. L.124-18 of the education code). Each period of at least 7 hours of presence, whether consecutive or otherwise, is considered equivalent to one day of internship work, and each period equal to at least 22 days of presence, consecutive or otherwise, is considered equivalent to one month. La durée totale du stage est appréciée en tenant compte de la présence effective du stagiaire dans l’organisme, sous réserve des droits à congés et autorisations d’absence prévus à l’article L.124-13 du code de l’éducation (art. L.124-18 du code de l’éducation). Chaque période au moins égale à 7 heures de présence consécutives ou non est considérée comme équivalente à un jour de stage et chaque période au moins égale à 22 jours de présence consécutifs ou non est considérée comme équivalente à un mois.

Related to A STUDENT

  • STUDENT For the purpose of this Collective Agreement, the term Student shall mean a person who, except for summer vacation period or work study period, would normally be attending full time at High School, Vocational School, or University and taking subjects relating to the Refrigeration and Air Conditioning Trade. The intention of this clause is to enable the Employer to give practical experience during summer months to a person whose declared intention is to seek employment in the Trade upon graduation from school, and is not intended as a source of casual labour.

  • Research Program Funding During the period commencing on the Effective Date and continuing until the expiration of the Term, Lilly shall pay ImmunoGen the FTE Cost for the conduct of ImmunoGen Activities on a quarterly basis in arrears. Within [***] days following the last day of each Calendar Quarter during the Term, ImmunoGen shall provide a report and invoice setting forth the aggregate number of hours devoted by ImmunoGen employees in performing ImmunoGen Activities during such Calendar Quarter [***]. Within [***] days from the date of its receipt of each such invoice, Lilly will pay to ImmunoGen the invoice amount due as reimbursement for the ImmunoGen Activities in accordance with Section 5.3 hereof. If Lilly disputes any charge contained in an invoice, it will pay any undisputed amount in accordance with the preceding sentence, and the disputed amount will be addressed under the dispute resolution provisions of Section 11.12 hereof. Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones)

  • Development Funding (a) Viewray will pay 3D Line the then U.S. Dollar equivalent of €[***] within three (3) days of the Effective Date for the engineering services required to develop/ deliver the Deliverable described in Section 2.1(a)(i).

  • Development Activities 3.4. The Development activities referred to in item “b” of paragraph 3.1 include:

  • Educational Program Section 1: Nurses covered by this Agreement will receive the university fee authorization program and dependent fee authorization program as currently in effect and as may be determined during the term of this agreement.

  • Research Program 2.1 University will use reasonable efforts to conduct the Research Program described in Attachment A which is hereby incorporated in full by reference (“Research Program”), and will furnish the facilities necessary to carry out said Research Program. The Research Program will be under the direction of _____________________ (“Principal Investigator”), or his or her successor as mutually agreed to by the Parties and will be con­ducted by the Principal Investigator at the University.

  • Student Teachers No employee will be assigned a student teacher without his/her prior consent and knowledge of such an assignment. When possible, such assignment shall be announced at least two (2) weeks in advance of the student teacher's arrival.

  • Research Funding During the Collaboration Term, including any extension thereof, Roche Bioscience agrees to provide Axys with research funding for a total of [*] at an annual rate of [*] to be used by Axys to pursue the activities set forth in the Research Plan; provided, however, that, in the event that the Collaboration Term is extended pursuant to Section 2.5, the annual rate per FTE will be increased for such extension period by a factor which reflects the increase, if any, in the U.S. Consumer Price Index, as reported as of the date that is sixty (60) days prior to the commencement of such extension period when compared to the comparable statistic for the Effective Date. Such research funding payments shall be made in accordance with the following schedule: AMOUNT OF PAYMENT DATE PAYABLE [*] [*] after the Effective Date [*] [*] following the Effective Date [*] [*] after receipt of Final NemaPharm Report pursuant to Section 3.5 and statement of account.

  • Development Plan The Parties’ respective responsibilities for the Development of the Collaboration Compounds and the Products are set forth in this Article 4. As of the Execution Date, the Parties have agreed upon a Development Plan for the Development of Product(s), attached to this Agreement as Exhibit A. The Development Plan may be revised from time to time by the JDC. Either Party may propose modifications to the Development Plan for Development of a Product, including clinical trial plans and time lines, and such proposed modifications shall be subject to review and approval by the JDC, provided that with respect to a Material Development Plan Amendment, a Party may propose such modifications directly to the JSC. Upon approval by the JDC (or JSC, as applicable), such modifications shall become part of the Development Plan. All Development Plans must require periodic reassessment and re-approval (each a “Go/No-go Decision”) after each clinical trial or at such times as the JDC in its discretion deems appropriate, at which point continuation of relevant Development activities shall be subject to the approval of the JDC in view of then applicable scientific, clinical, safety, [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. financial and commercial factors. The Development Plan shall allocate Development activities between the Parties, based on the following principles: (i) with respect to Product(s) comprising the Lead Compound, Portola will be the lead Party for Development activities [*]; (ii) with respect to any Product comprising a Back-Up Compound, Portola will be the lead Party for Development activities until [*] for such Product; (iii) Portola has the right (but not the obligation) to be the lead Party for Development activities [*]; (iv) Biogen Idec shall be the lead party for [*] for the Products; and (v) Portola shall be the lead Party [*]. The lead Party for Development activities pertaining to any Product shall have the primary responsibility for the performance of the Development Activities according to the Development Plan and within the Development Budget. In the course of fulfilling its role as the lead developing Party for a particular Product in a particular Indication and during a particular stage of the Product Development, a Party may request the other Party to conduct certain specific Development activities, and the other Party shall have the right to accept or reject such request, at its sole discretion. In addition, Biogen Idec will include Portola in Development activities involving scientific leaders and experts worldwide, including participation in advisory board meetings.